Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Genotyping Assay Market by Type (Instruments, Reagents & Kits), By Application (Pharmaceutical and Biopharmaceutical Companies, Diagnostic and Research Laboratories, Academic Institutes, Others) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Genotyping Assay Market by Type (Instruments, Reagents & Kits), By Application (Pharmaceutical and Biopharmaceutical Companies, Diagnostic and Research Laboratories, Academic Institutes, Others) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 192896 3300 Medical Devices & Consumables 377 247 Pages 4.9 (45)
                                          

The global genotyping assay market is expected to grow at a CAGR of 7.5% during the forecast period, from 2021 to 2030. The growth of this market is driven by the increasing demand for personalized medicine and genetic testing in various applications such as cancer diagnosis, drug discovery, and disease management. The global genotyping assay market is segmented on the basis of type into instruments, reagents & kits, and application into pharmaceutical and biopharmaceutical companies, diagnostic and research laboratories, academic institutes. The North American region dominates the global genotyping assay market with a share of over 40%. This can be attributed to factors such as high adoption rates for personalized medicine in this region due to its high healthcare expenditure per capita.

Some Of The Growth Factors Of This Market:

  1. Increasing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases are driving the growth of the Genotyping Assay market.
  2. Increasing demand for personalized medicine is also driving the growth of the Genotyping Assay market.
  3. Technological advancements in genomics research and development are also driving the growth of this market.
  4. The increasing number of collaborations between pharmaceutical companies and biotechnology companies is also driving this market.

Industry Growth Insights published a new data on “Genotyping Assay Market”. The research report is titled “Genotyping Assay Market research by Types (Instruments, Reagents & Kits), By Applications (Pharmaceutical and Biopharmaceutical Companies, Diagnostic and Research Laboratories, Academic Institutes, Others), By Players/Companies Danaher, Roche, GE, Thermo Fisher Scientific, Agilent Technologies, Illumina, Bio-Rad Laboratories, Qiagen, Perkinelmer, Fluidigm, Brooks Automation (Genewiz), Eurofins Scientific, Pacific Biosciences of California”.

Scope Of The Report

Report Attributes

Report Details

Report Title

Genotyping Assay Market Research Report

By Type

Instruments, Reagents & Kits

By Application

Pharmaceutical and Biopharmaceutical Companies, Diagnostic and Research Laboratories, Academic Institutes, Others

By Companies

Danaher, Roche, GE, Thermo Fisher Scientific, Agilent Technologies, Illumina, Bio-Rad Laboratories, Qiagen, Perkinelmer, Fluidigm, Brooks Automation (Genewiz), Eurofins Scientific, Pacific Biosciences of California

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

247

Number of Tables & Figures

173

Customization Available

Yes, the report can be customized as per your need.


Global Genotyping Assay Industry Outlook


Global Genotyping Assay Market Report Segments:

The global Genotyping Assay market is segmented on the basis of:

Types

Instruments, Reagents & Kits

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Pharmaceutical and Biopharmaceutical Companies, Diagnostic and Research Laboratories, Academic Institutes, Others

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Danaher
  2. Roche
  3. GE
  4. Thermo Fisher Scientific
  5. Agilent Technologies
  6. Illumina
  7. Bio-Rad Laboratories
  8. Qiagen
  9. Perkinelmer
  10. Fluidigm
  11. Brooks Automation (Genewiz)
  12. Eurofins Scientific
  13. Pacific Biosciences of California

Global Genotyping Assay Market Overview


Highlights of The Genotyping Assay Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Instruments
    2. Reagents & Kits
  1. By Application:

    1. Pharmaceutical and Biopharmaceutical Companies
    2. Diagnostic and Research Laboratories
    3. Academic Institutes
    4. Others
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Genotyping Assay Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Genotyping Assay Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


A genotyping assay is a laboratory test that uses DNA to determine the genetic makeup of an individual. This information can be used to identify specific genes and mutations within those genes.

Some of the major companies in the genotyping assay market are Danaher, Roche, GE, Thermo Fisher Scientific, Agilent Technologies, Illumina, Bio-Rad Laboratories, Qiagen, Perkinelmer, Fluidigm, Brooks Automation (Genewiz), Eurofins Scientific, Pacific Biosciences of California.

The genotyping assay market is expected to register a CAGR of 7.5%.

                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Genotyping Assay Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Genotyping Assay Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Genotyping Assay Market - Supply Chain
   4.5. Global Genotyping Assay Market Forecast
      4.5.1. Genotyping Assay Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Genotyping Assay Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Genotyping Assay Market Absolute $ Opportunity

5. Global Genotyping Assay Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Genotyping Assay Market Size and Volume Forecast by Type
      5.3.1. Instruments
      5.3.2. Reagents & Kits
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Genotyping Assay Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Genotyping Assay Market Size and Volume Forecast by Application
      6.3.1. Pharmaceutical and Biopharmaceutical Companies
      6.3.2. Diagnostic and Research Laboratories
      6.3.3. Academic Institutes
      6.3.4. Others
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Genotyping Assay Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Genotyping Assay Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Genotyping Assay Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Genotyping Assay Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Genotyping Assay Demand Share Forecast, 2019-2026

9. North America Genotyping Assay Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Genotyping Assay Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Genotyping Assay Market Size and Volume Forecast by Application
      9.4.1. Pharmaceutical and Biopharmaceutical Companies
      9.4.2. Diagnostic and Research Laboratories
      9.4.3. Academic Institutes
      9.4.4. Others
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Genotyping Assay Market Size and Volume Forecast by Type
      9.7.1. Instruments
      9.7.2. Reagents & Kits
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Genotyping Assay Demand Share Forecast, 2019-2026

10. Latin America Genotyping Assay Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Genotyping Assay Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Genotyping Assay Market Size and Volume Forecast by Application
      10.4.1. Pharmaceutical and Biopharmaceutical Companies
      10.4.2. Diagnostic and Research Laboratories
      10.4.3. Academic Institutes
      10.4.4. Others
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Genotyping Assay Market Size and Volume Forecast by Type
      10.7.1. Instruments
      10.7.2. Reagents & Kits
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Genotyping Assay Demand Share Forecast, 2019-2026

11. Europe Genotyping Assay Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Genotyping Assay Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Genotyping Assay Market Size and Volume Forecast by Application
      11.4.1. Pharmaceutical and Biopharmaceutical Companies
      11.4.2. Diagnostic and Research Laboratories
      11.4.3. Academic Institutes
      11.4.4. Others
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Genotyping Assay Market Size and Volume Forecast by Type
      11.7.1. Instruments
      11.7.2. Reagents & Kits
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Genotyping Assay Demand Share, 2019-2026

12. Asia Pacific Genotyping Assay Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Genotyping Assay Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Genotyping Assay Market Size and Volume Forecast by Application
      12.4.1. Pharmaceutical and Biopharmaceutical Companies
      12.4.2. Diagnostic and Research Laboratories
      12.4.3. Academic Institutes
      12.4.4. Others
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Genotyping Assay Market Size and Volume Forecast by Type
      12.7.1. Instruments
      12.7.2. Reagents & Kits
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Genotyping Assay Demand Share, 2019-2026

13. Middle East & Africa Genotyping Assay Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Genotyping Assay Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Genotyping Assay Market Size and Volume Forecast by Application
      13.4.1. Pharmaceutical and Biopharmaceutical Companies
      13.4.2. Diagnostic and Research Laboratories
      13.4.3. Academic Institutes
      13.4.4. Others
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Genotyping Assay Market Size and Volume Forecast by Type
      13.7.1. Instruments
      13.7.2. Reagents & Kits
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Genotyping Assay Demand Share, 2019-2026

14. Competition Landscape
   14.1. Global Genotyping Assay Market: Market Share Analysis
   14.2. Genotyping Assay Distributors and Customers
   14.3. Genotyping Assay Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. Danaher
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. Roche
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. GE
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. Thermo Fisher Scientific
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. Agilent Technologies
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. Illumina
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. Bio-Rad Laboratories
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. Qiagen
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. Perkinelmer
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. Fluidigm
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. Brooks Automation (Genewiz)
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. Eurofins Scientific
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. Pacific Biosciences of California
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. COMPANY 14
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. COMPANY 15
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. COMPANY 16
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. COMPANY 17
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. COMPANY 18
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. COMPANY 19
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. COMPANY 20
         14.4.20.1. Overview
         14.4.20.2. Financials
         14.4.20.3. Developments
         14.4.20.4. Strategic Outlook

Our Trusted Clients

Contact Us